These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 8970613

  • 1. Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine.
    Taler SJ, Textor SC, Canzanello VJ, Schwartz L, Porayko M, Wiesner RH, Krom RA.
    Transplantation; 1996 Dec 15; 62(11):1588-92. PubMed ID: 8970613
    [Abstract] [Full Text] [Related]

  • 2. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.
    Stegall MD, Wachs ME, Everson G, Steinberg T, Bilir B, Shrestha R, Karrer F, Kam I.
    Transplantation; 1997 Dec 27; 64(12):1755-60. PubMed ID: 9422416
    [Abstract] [Full Text] [Related]

  • 3. Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
    Cao S, Cox KL, Berquist W, Hayashi M, Concepcion W, Hammes GB, Ojogho OK, So SK, Frerker M, Castillo RO, Monge H, Esquivel CO.
    Pediatr Transplant; 1999 Feb 27; 3(1):22-6. PubMed ID: 10359027
    [Abstract] [Full Text] [Related]

  • 4. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H, Moal V, Indreies M, Purgus R, Loundou A, Burtey S, Brunet P, Moussi-Frances J, Daniel L, Dussol B, Berland Y.
    Transplantation; 2012 Feb 27; 93(4):437-43. PubMed ID: 22228415
    [Abstract] [Full Text] [Related]

  • 5. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 6. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 15; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 7. A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients.
    Hardinger KL, Bohl DL, Schnitzler MA, Lockwood M, Storch GA, Brennan DC.
    Transplantation; 2005 Jul 15; 80(1):41-6. PubMed ID: 16003231
    [Abstract] [Full Text] [Related]

  • 8. Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus.
    Fuchs U, Zittermann A, Ensminger SM, Schulz U, Gummert JF.
    Transpl Immunol; 2014 Aug 15; 31(2):87-91. PubMed ID: 24932812
    [Abstract] [Full Text] [Related]

  • 9. Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients.
    Textor SC, Wiesner R, Wilson DJ, Porayko M, Romero JC, Burnett JC, Gores G, Hay E, Dickson ER, Krom RA.
    Transplantation; 1993 Jun 15; 55(6):1332-9. PubMed ID: 7685934
    [Abstract] [Full Text] [Related]

  • 10. Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: a NAPRTCS study.
    Neu AM, Ho PL, Fine RN, Furth SL, Fivush BA.
    Pediatr Transplant; 2003 Jun 15; 7(3):217-22. PubMed ID: 12756047
    [Abstract] [Full Text] [Related]

  • 11. Late hypertension after liver transplantation: a comparison of cyclosporine and tacrolimus (FK 506).
    Canzanello VJ, Textor SC, Taler SJ, Schwartz LL, Porayko MK, Wiesner RH, Krom RA.
    Liver Transpl Surg; 1998 Jul 15; 4(4):328-34. PubMed ID: 9649648
    [Abstract] [Full Text] [Related]

  • 12. Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients?
    Meiser BM, Groetzner J, Kaczmarek I, Landwehr P, Müller M, Jung S, Uberfuhr P, Fraunberger P, Stempfle HU, Weis M, Reichart B.
    Transplantation; 2004 Aug 27; 78(4):591-8. PubMed ID: 15446320
    [Abstract] [Full Text] [Related]

  • 13. Randomized trial of cyclosporine and tacrolimus therapy with steroid withdrawal in living-donor renal transplantation: 5-year follow-up.
    Lee YJ, Kim B, Lee JE, Kim YG, Kim DJ, Kim SJ, Joh JW, Oh HY, Huh W.
    Transpl Int; 2010 Feb 27; 23(2):147-54. PubMed ID: 19744223
    [Abstract] [Full Text] [Related]

  • 14. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus.
    Taylor DO, Barr ML, Radovancevic B, Renlund DG, Mentzer RM, Smart FW, Tolman DE, Frazier OH, Young JB, VanVeldhuisen P.
    J Heart Lung Transplant; 1999 Apr 27; 18(4):336-45. PubMed ID: 10226898
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine.
    Stegall MD, Simon M, Wachs ME, Chan L, Nolan C, Kam I.
    Transplantation; 1997 Dec 27; 64(12):1695-700. PubMed ID: 9422404
    [Abstract] [Full Text] [Related]

  • 16. Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study.
    Rathi M, Rajkumar V, Rao N, Sharma A, Kumar S, Ramachandran R, Kumar V, Kohli HS, Gupta KL, Sakhuja V.
    Transplant Proc; 2015 May 27; 47(4):1158-61. PubMed ID: 26036543
    [Abstract] [Full Text] [Related]

  • 17. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M, Pellegrini C, Martinelli L, Goggi C, Gavazzi A, Campana C, Arbustini E, Grossi P, Regazzi M, Ippoliti G, Vigano M.
    J Heart Lung Transplant; 1997 Oct 27; 16(10):1001-10. PubMed ID: 9361242
    [Abstract] [Full Text] [Related]

  • 18. A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants.
    Raofi V, Holman DM, Coady N, Vazquez E, Dunn TB, Bartholomew AM, Pollak R, Benedetti E.
    Am J Surg; 1999 Apr 27; 177(4):299-302. PubMed ID: 10326847
    [Abstract] [Full Text] [Related]

  • 19. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.
    Jain A, Mazariegos G, Kashyap R, Green M, Gronsky C, Starzl TE, Fung J, Reyes J.
    Transplantation; 2000 Aug 27; 70(4):617-25. PubMed ID: 10972220
    [Abstract] [Full Text] [Related]

  • 20. Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results.
    Chamienia A, Dębska-Ślizień A, Król E, Biedunkiewicz B, Rutkowski B.
    Transplant Proc; 2014 Oct 27; 46(8):2714-8. PubMed ID: 25380901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.